Why Cochlear Limited shares spiked this morning

The window of opportunity to buy Cochlear shares at a good price may be closing…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in hearing device manufacturer Cochlear Limited (ASX: COH) are up 3.4% today to $61.90 at the time of writing. The ostensible reason for the rise is that the company announced it would launch the Cochlear Nucleus Profile Series across Europe in June.

While there is nothing groundbreaking in this announcement (it was expected), it has given the share price some much needed impetus. I suggested in April that Cochlear might be the beneficiary of what is called a short squeeze. A short squeeze occurs when a heavily shorted company announces some good news. As a result, short sellers all rush to cover or reduce their positions at the same time, sending the share price higher, which in turn triggers "stop losses" causing more short sellers to cover, pushing the price higher still.

In order to predict whether there is the potential for a short squeeze, we'll need to look at the average turnover. In the last five months, an average of 207,500 Cochlear shares have been traded each day. That is a measly 0.36% of the total number of shares.

At 26 May, over 17% of Cochlear was still sold short.

If we assume that volume will be somewhat higher and that short sellers are going to buy most of the shares on offer, then it will take at least two months for short sellers to cover their positions. All that is now required is for a couple of big funds to get involved and push up the price of Cochlear shares.

Cochlear is short sold because it is losing market share to its Swiss rival Sonova, and its dividend is unsustainable at a hefty 4.1%. However, the flip side of the argument is that Cochlear's new platform for hearing implants, to which today's announcement refers, could stop the company losing any more market share. Furthermore, it was just last month that the Cochlear CEO told The Australian that the company, "was well placed to take advantage of the forecast increase in public health investment flagged by the Chinese government." For quite some time, I've been suggesting readers buy Cochlear shares while the company is out of favour, because the ageing population is a tailwind so strong as to have the potential to overcome competitive pressures.

Motley Fool contributor Claude Walker (@claudedwalker) does not own shares in any of  the companies mentioned in this article

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »